Bio-Rad Labs Inc. A buy UBS Group AG
Start price
03.05.25
/
50%
€205.90
Target price
03.05.26
€274.38
Performance (%)
5.49%
End price
04.05.26
€217.20
Summary
This prediction ended on 04.05.26 with a price of €217.20. The BUY prediction by UBS_Group_AG finished with a performance of 5.49%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | 2.732% | 2.732% | 16.037% |
| iShares Core DAX® | 2.591% | 2.467% | 8.839% |
| iShares Nasdaq 100 | -0.915% | -6.458% | 24.933% |
| iShares Nikkei 225® | 0.145% | -8.773% | 47.385% |
| iShares S&P 500 | -0.367% | -1.220% | 21.667% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $355.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
-12.97%
09.05.25
09.05.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
8.65%
08.12.24
08.12.24